Royal Devon and Exeter NHS Foundation Trust
91
7
16
55
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.4%
4 terminated/withdrawn out of 91 trials
93.2%
+6.7% vs industry average
8%
7 trials in Phase 3/4
7%
4 of 55 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (91)
Co-designing a Stroke Rehabilitation Trial Toolkit
Role: collaborator
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
Role: collaborator
An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.
Role: collaborator
Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)
Role: collaborator
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
Role: collaborator
Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes
Role: collaborator
Understanding Cauda Equina Syndrome
Role: collaborator
Adapting Body Reprogramming for Severe Asthma: a Feasibility Study
Role: lead
Deep Brain Stimulation in Tourette Syndrome
Role: collaborator
Experience of Biologic Treatments for Severe Asthma: a Survey
Role: lead
Predicting Incidental Gallbladder Cancer
Role: collaborator
Interstitial Lung Disease Exacerbations Study
Role: lead
Development of a Novel Screening Tool for Anosognosia After Stroke.
Role: collaborator
Dietary Supplementation With Blueberry in OA
Role: collaborator
A Study Using Metaphyseal Cones Versus a Cemented Stem Construct in Revision TKR
Role: lead
Fixed Versus Adjustable Loop in ACL Reconstruction
Role: lead
Assessing Remote Confirmation of Type 1 Diabetes
Role: lead
Uncemented Tritanium TKR vs Cemented Triathlon TKR
Role: lead
Reconstruction in Extended MArgin Cancer Surgery
Role: collaborator
Traditional Versus Alternative Alignment in TKR
Role: lead